Massimo Broggini

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 26

Top Topics

Tyrosine Kinase

Myasthenia Gravis

Silver Nanoparticles

Top Venues

Journal of experimental & clinical cancer research : CR

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Gloriana Ndembe, Ilenia Intini, Massimo Moro, Chiara Grasselli, Andrea Panfili, Nicolò Panini, Augusto Bleve, Mario Occhipinti, Cristina Borzi, Marina Chiara Garassino, Mirko Marabese, Simone Canesi, Eugenio Scanziani, Gabriella Sozzi, Massimo Broggini, Monica Ganzinelli
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Gloriana Ndembe, Ilenia Intini, Massimo Moro, Chiara Grasselli, Andrea Panfili, Nicolò Panini, Augusto Bleve, Mario Occhipinti, Cristina Borzi, Marina Chiara Garassino, Mirko Marabese, Simone Canesi, Eugenio Scanziani, Gabriella Sozzi, Massimo Broggini, Monica Ganzinelli
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Gloriana Ndembe, Ilenia Intini, Massimo Moro, Chiara Grasselli, Andrea Panfili, Nicolò Panini, Augusto Bleve, Mario Occhipinti, Cristina Borzi, Marina Chiara Garassino, Mirko Marabese, Simone Canesi, Eugenio Scanziani, Gabriella Sozzi, Massimo Broggini, Monica Ganzinelli
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy. Journal of experimental & clinical cancer research : CR 43 (1) (2024)
Paolo Mendogni, Roberta Affatato, Enrico Cabri, Michela Chiappa, Gloriana Ndembe, Davide Tosi, Alessandro Del Gobbo, Maddalena Fratelli, Eleonora Pardini, Iacopo Petrini, Lorenzo Rosso, Massimo Broggini, Mirko Marabese
Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Marika Colombo, Federico Passarelli, Paola Antonia Corsetto, Angela Maria Rizzo, Mirko Marabese, Giulia De Simone, Roberta Pastorelli, Massimo Broggini, Laura Brunelli, Elisa Caiola
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2). Cells 11 (23) (2022)
Marika Colombo, Federico Passarelli, Paola Antonia Corsetto, Angela Maria Rizzo, Mirko Marabese, Giulia De Simone, Roberta Pastorelli, Massimo Broggini, Laura Brunelli, Elisa Caiola
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2). Cells 11 (23) (2022)
Paolo Mendogni, Roberta Affatato, Enrico Cabri, Michela Chiappa, Gloriana Ndembe, Davide Tosi, Alessandro Del Gobbo, Maddalena Fratelli, Eleonora Pardini, Iacopo Petrini, Lorenzo Rosso, Massimo Broggini, Mirko Marabese
Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Marika Colombo, Federico Passarelli, Paola Antonia Corsetto, Angela Maria Rizzo, Mirko Marabese, Giulia De Simone, Roberta Pastorelli, Massimo Broggini, Laura Brunelli, Elisa Caiola
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2). Cells 11 (23) (2022)
Marika Colombo, Federico Passarelli, Paola Antonia Corsetto, Angela Maria Rizzo, Mirko Marabese, Giulia De Simone, Roberta Pastorelli, Massimo Broggini, Laura Brunelli, Elisa Caiola
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2). Cells 11 (23) (2022)
Paolo Mendogni, Roberta Affatato, Enrico Cabri, Michela Chiappa, Gloriana Ndembe, Davide Tosi, Alessandro Del Gobbo, Maddalena Fratelli, Eleonora Pardini, Iacopo Petrini, Lorenzo Rosso, Massimo Broggini, Mirko Marabese
Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Marika Colombo, Federico Passarelli, Paola Antonia Corsetto, Angela Maria Rizzo, Mirko Marabese, Giulia De Simone, Roberta Pastorelli, Massimo Broggini, Laura Brunelli, Elisa Caiola
NSCLC Cells Resistance to PI3K/mTOR Inhibitors Is Mediated by Delta-6 Fatty Acid Desaturase (FADS2). Cells 11 (23) (2022)
Ludmila V Puchkova, Irina V Kiseleva, Elena V Polishchuk, Massimo Broggini, Ekaterina Yu Ilyechova
The Crossroads between Host Copper Metabolism and Influenza Infection. International journal of molecular sciences 22 (11) (2021)
Nour Ghaddar, Shuo Wang, Bethany Woodvine, Jothilatha Krishnamoorthy, Vincent van Hoef, Cedric Darini, Urszula Kazimierczak, Nicolas Ah-Son, Helmut H Popper, Myriam Johnson, Leah Officer, Ana Teodosio, Massimo Broggini, Koren K Mann, Maria Hatzoglou, Ivan Topisirovic, Ola Larsson, John P C Le Quesne, Antonis E Koromilas
The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer. Nature communications 12 (1) (2021)
Elisa Caiola, Massimo Broggini
It's Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC? Cancers 12 (11) (2020)
Aikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, Tania Maffucci, Luc Furic, Federica Guffanti, Massimo Broggini, Xi Chen, Yulia Y Maxuitenko, Adam B Keeton, Gary A Piazza, Kenneth J Linton, Marco Falasca
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy. Cancers 12 (8) (2020)
Elisa Caiola, Marika Colombo, Giovanna Sestito, Monica Lupi, Mirko Marabese, Roberta Pastorelli, Massimo Broggini, Laura Brunelli
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation. Cells 9 (8) (2020)
Roberta Affatato, Paolo Mendogni, Alessandro Del Gobbo, Stefano Ferrero, Francesca Ricci, Massimo Broggini, Lorenzo Rosso
Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients. Cancers 12 (12) (2020)
Maria Francesca Alvisi, Monica Ganzinelli, Helena Linardou, Elisa Caiola, Giuseppe Lo Russo, Fabiana Letizia Cecere, Anna Cecilia Bettini, Amanda Psyrri, Michele Milella, Eliana Rulli, Alessandra Fabbri, Marcella De Maglie, Pierpaolo Romanelli, Samuel Murray, Gloriana Ndembe, Massimo Broggini, Marina Chiara Garassino, Mirko Marabese
Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy. Journal of clinical medicine 9 (8) (2020)
Irina V Kiseleva, Mohammad Al Farroukh, Ekaterina A Skomorokhova, Andrei R Rekstin, Ekaterina A Bazhenova, Daria N Magazenkova, Iurii A Orlov, Larisa G Rudenko, Massimo Broggini, Ludmila V Puchkova
Anti-Influenza Effect of Nanosilver in a Mouse Model. Vaccines 8 (4) (2020)
Ludmila V Puchkova, Massimo Broggini, Elena V Polishchuk, Ekaterina Y Ilyechova, Roman S Polishchuk
Silver Ions as a Tool for Understanding Different Aspects of Copper Metabolism. Nutrients 11 (6) (2019)
Ekaterina Y Ilyechova, Elisa Bonaldi, Iurii A Orlov, Ekaterina A Skomorokhova, Ludmila V Puchkova, Massimo Broggini
CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences. Cells 8 (4) (2019)
Oscar Corli, Giovanna Damia, Francesca Galli, Carmen Verrastro, Massimo Broggini
Lack of Efficacy: When Opioids Do Not Achieve Analgesia from the Beginning of Treatment in Cancer Patients. Cancer management and research 11 (2019)
Giovanna Damia, Massimo Broggini
Platinum Resistance in Ovarian Cancer: Role of DNA Repair. Cancers 11 (1) (2019)
Anna Tessari, Kareesma Parbhoo, Meghan Pawlikowski, Angelo Paolo Dei Tos, Eliana Rulli, Claudia Foray, Alessandra Fabbri, Valerio Embrione, Monica Ganzinelli, Marina Capece, Moray J Campbell, Massimo Broggini, Krista La Perle, Gabriella Farina, Sara Cole, Mirko Marabese, Marianna Hernandez, Joseph M Amann, Giancarlo Pruneri, David P Carbone, Marina C Garassino, Carlo M Croce, Dario Palmieri, Vincenzo Coppola
RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients. Oncogene 37 (50) (2018)
Alice Iezzi, Elisa Caiola, Arianna Scagliotti, Massimo Broggini
Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells. BMC cancer 18 (1) (2018)
Elisa Caiola, Roberta Frapolli, Michele Tomanelli, Rossana Valerio, Alice Iezzi, Marina C Garassino, Massimo Broggini, Mirko Marabese
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib. Scientific reports 8 (1) (2018)
Elisa Caiola, Eleonora Marrazzo, Simona Alesci, Massimo Broggini, Mirko Marabese
∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 37 (2) (2015)